However, the overall impact of GBA mutations on the incidence of dementia in PD remains low given that these mutations account for only 3–4% of PD cases (38, 39), and it is unclear how relevant such therapeutic strategies might be in idiopathic PD. Here, GBA1 is linked to Parkinson disease.